Literature DB >> 20490659

Effects of hydroxyurea on monoclonal antibody production induced by anti-mIgG and LPS stimulation on murine B cell hybridomas.

Alicia Martín-López1, Asterio Sánchez-Mirón, Francisco García-Camacho, Antonio Contreras-Gómez, Emilio Molina-Grima.   

Abstract

Chemical treatment with hydroxyurea (HU) has been selected as a simple and low cost strategy to generate a cell population enriched for the G1 phase. After the chemical treatment with HU, cells were stimulated with anti-mIgG to test if the positive effects of anti-mIgG on CD40 expression and specific IgG2a production rate were improved upon a cell population with a higher percentage of cells in G1 phase at the beginning of the cell culture. In addition, other treatments assayed in this work were the cell stimulation with Lipopolysaccharide (LPS) both before and after the HU treatment. It has been observed that the use of HU under conditions able to maintain the cells in viable state (0.1 mM for 20 h), has a negative effect on CD40 expression and specific IgG2a production rate induced by anti-mIgG. The positive effect of LPS on cell stimulation induced by anti-mIgG is reduced on cells treated with HU.

Entities:  

Year:  2010        PMID: 20490659      PMCID: PMC2932903          DOI: 10.1007/s10616-010-9278-9

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  54 in total

1.  Relationship between hybridoma growth and monoclonal antibody production.

Authors:  P M Hayter; N F Kirkby; R E Spier
Journal:  Enzyme Microb Technol       Date:  1992-06       Impact factor: 3.493

2.  Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures.

Authors:  M al-Rubeai; A N Emery; S Chalder; D C Jan
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 3.  An overview of the clinical experience with hydroxyurea.

Authors:  R C Donehower
Journal:  Semin Oncol       Date:  1992-06       Impact factor: 4.929

4.  Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.

Authors:  Sheley Gambero; Andreia A Canalli; Fabiola Traina; Dulcinéia M Albuquerque; Sara T O Saad; Fernando F Costa; Nicola Conran
Journal:  Eur J Haematol       Date:  2007-02       Impact factor: 2.997

5.  Rapamycin reduces hybridoma cell death and enhances monoclonal antibody production.

Authors:  R R Balcarcel; G Stephanopoulos
Journal:  Biotechnol Bioeng       Date:  2001       Impact factor: 4.530

6.  Correlation between cell enlargement and nucleic acid and protein content of HeLa cells in unbalanced growth produced by inhibitors of DNA synthesis.

Authors:  L S Cohen; G P Studzinski
Journal:  J Cell Physiol       Date:  1967-06       Impact factor: 6.384

7.  Evaluation of S phase synchronization by analysis of DNA replication in 5-bromodeoxyuridine.

Authors:  R E Meyn; R R Hewitt; R M Humphrey
Journal:  Exp Cell Res       Date:  1973-11       Impact factor: 3.905

8.  Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea.

Authors:  L A Styles; B Lubin; E Vichinsky; S Lawrence; M Hua; S Test; F Kuypers
Journal:  Blood       Date:  1997-04-01       Impact factor: 22.113

9.  Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase.

Authors:  Vladan P Cokic; Reginald D Smith; Bojana B Beleslin-Cokic; Joyce M Njoroge; Jeffery L Miller; Mark T Gladwin; Alan N Schechter
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 10.  Effects of sodium butyrate, a new pharmacological agent, on cells in culture.

Authors:  J Kruh
Journal:  Mol Cell Biochem       Date:  1982-02-05       Impact factor: 3.396

View more
  1 in total

1.  Co-culture of the 55-6 B cell hybridoma with the EL-4 thymoma cell. Effect on cell growth and monoclonal antibody production.

Authors:  Alicia Martín-López; Lourdes Acosta-López; Francisco García-Camacho; Antonio Contreras-Gómez; Emilio Molina-Grima
Journal:  Cytotechnology       Date:  2013-06-14       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.